Delivery Order SPE2DB20D9135-SPE2DB23FZW30
Award Date
5/8/23
Potential Completion Date
5/30/23
Potential Value
$6.2K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order (SPE2DB22FD2ZM) valued at $9,825.60 for the supply of the pharmaceutical product Xolair 150 mg/ml syringe. The award was made by the Defense Logistics Agency (DLA), a defense agency, on May 5, 2022, with a completion date of May 26, 2022. DMS Pharmaceutical Group is a key supplier of a wide range of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $9,671.25 firm fixed-price delivery order is for the pharmaceutical product XOLAIR 150 MG/ML SYRINGEML, with a completion date of June 4, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order worth $3,868.50 for the provision of Xolair 150 mg/mL syringes. The contract is a firm fixed-price award with no set-aside designation, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to issue delivery orders for a wide...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $7,737.00 for the supply of Xolair 150 mg/ml syringes. The award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, which facilitates the distribution of pharmaceutical products and medical supplies to Department of Defense (DoD) healthcare facilities worldwide. The contract has no set-aside designation and is part of a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the DLA's SPE2DB Prime Vendor program. The contract, valued at $4,642.20, is for the delivery of the pharmaceutical product Xolair 150 mg/mL syringe to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of medications,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a Firm Fixed Price Delivery Order with a ceiling value of $7,737.00. The contract was awarded by the Defense Logistics Agency (DLA) to supply the pharmaceutical product Xolair 150 mg/1.2 ml powder for injection. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical supplies to support the recurring medical needs...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of Xolair 150 mg/ml syringes. The $9,284.40 firm fixed-price delivery order was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain division, which supports the recurring pharmaceutical needs of Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities nationwide. DMS Pharmaceutical Group holds a significant...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order worth $7,737 under the Defense Logistics Agency's (DLA) SPE2DB24FL1C9 indefinite delivery contract. The contract is for the supply of the pharmaceutical product XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML, with an ultimate completion date of June 7, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) as a delivery order valued at $37,137.60. The contract provides for the delivery of Xolair 150 mg/mL syringes to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The $4,642.20 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/ML SYRINGEML, a specialty pharmaceutical product, to fulfill the recurring medical supply needs of military health facilities. The award is not associated with any set-aside program. DMS Pharmaceutical Group holds a...